Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Bausch + Lomb Corporation (BLCO)

Ophthalmic Goods

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

520 APPLEWOOD CRESCENT
VAUGHAN, A6

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/06/2022

Market Cap

5,612,366,078

Shares Outstanding

350,860,000

Weighted SO

350,855,769

Total Employees

N/A

Upcoming Earnings

07/31/2024

Beta

0.4690

Last Div

0.0000

Range

13.16-20.06

Chg

-0.1100

Avg Vol

592322

Mkt Cap

5612366078

Exch

NYSE

Country

CA

Phone

905 695 7700

DCF Diff

-10.0738

DCF

26.0138

Div Yield

0.0000

P/S

1.2486

EV Multiple

17.9465

P/FV

0.8649

Div Yield %

0.0000

P/E

-12.3361

PEG

-4.5818

Payout

0.0000

Current Ratio

1.6521

Quick Ratio

1.0143

Cash Ratio

0.1802

DSO

82.0133

DIO

204.4995

Op Cycle

286.5128

DPO

77.4764

CCC

209.0364

Gross Margin

0.5755

Op Margin

0.0320

Pretax Margin

-0.0574

Net Margin

-0.1014

Eff Tax Rate

-0.7132

ROA

-0.0344

ROE

-0.0680

ROCE

0.0124

NI/EBT

1.7674

EBT/EBIT

-1.7917

EBIT/Rev

0.0320

Debt Ratio

0.3496

D/E

0.7122

LT Debt/Cap

0.4144

Total Debt/Cap

0.4159

Int Coverage

0.5255

CF/Debt

0.0256

Equity Multi

2.0372

Rec Turnover

4.4505

Pay Turnover

4.7111

Inv Turnover

1.7848

FA Turnover

3.1434

Asset Turnover

0.3392

OCF/Share

0.3371

FCF/Share

-0.3792

Cash/Share

0.8584

OCF/Sales

0.0264

FCF/OCF

-1.1249

CF Coverage

0.0256

ST Coverage

3.9535

CapEx Coverage

0.4706

Div&CapEx Cov

0.4706

P/BV

0.8649

P/B

0.8649

P/S

1.2486

P/E

-12.3361

P/FCF

-42.0677

P/OCF

47.4292

P/CF

47.4292

PEG

-4.5818

P/S

1.2486

EV Multiple

17.9465

P/FV

0.8649

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 01:15 Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research The Motley Fool Oct 14, 22:40 Why Bausch + Lomb Stock Soared by Over 7% on Monday Benzinga Sep 22, 21:34 Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? GlobeNewswire Inc. Jul 19, 05:31 Nicox announces attendance at upcoming conferences - GlobeNewswire GlobeNewswire Inc. Jul 16, 05:31 Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire Benzinga Nov 01, 07:32 Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' Benzinga Oct 30, 03:40 Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week Benzinga Oct 30, 03:40 Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week

Revenue Product Segmentation